Suliba®

Bosutinib

Product Information

  • Proprietary Name: Suliba®
  • Generic Name: Bosutinib
  • Dosage Form: Film-coated Tablet
  • Strengths: 100 mg
  • Indications: Chronic Myeloid Leukemia (CML)

Oncology

Suliba®

Bosutinib is indicated for the treatment of chronic myeloid leukemia (CML).

Ready to get started?

Curious about a specific position? Sign up for it.
© NanoAlvand. All rights reserved. Powered by ِDGN.